GGrantIndex
← Leaderboards

Winfried Edelmann

Yeshiva University

$16,942,262
Attributed
$18,547,244
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$18,547,244 · 8

By mechanism

R01$15,834,365 · 4
P30$2,256,379 · 3
R21$456,500 · 1

Top collaborators

Most similar at Yeshiva University

Same institution · by research overlap

Others in their field

Top investigators on “Base

Research focus

BaseGenesMalignant NeoplasmsMutationMismatch RepairDna RepairDefectKnock-In MouseMouse ModelTumorEmbryonic Stem CellTissuesProteinsGenomicsTumorigenesisResponseFundingGeneticPathway InteractionsComplexHereditary Nonpolyposis Colorectal NeoplasmsMolecularAffectCells

Grant awards (57)

Analyzing the Hypersensitivity of MMR-deficient Colorectal Cancers to mTOR Inhibition and the Response of Cancer Stem Cells$404,847
R01 · FY2025 · CA · contact PI
Animal Model Shared Resource$357,482
P30 · FY2025 · CA · contact PI
Analyzing the Hypersensitivity of MMR-deficient Colorectal Cancers to mTOR Inhibition and the Response of Cancer Stem Cells$384,604
R01 · FY2024 · CA · contact PI
Animal Model Shared Resource$330,297
P30 · FY2024 · CA · contact PI
Analyzing the Hypersensitivity of MMR-deficient Colorectal Cancers to mTOR Inhibition and the Response of Cancer Stem Cells$396,750
R01 · FY2023 · CA · contact PI
Animal Model Shared Resource$346,226
P30 · FY2023 · CA · contact PI
Genetic and Dietary Interactions in MMR Deficient Colon Tumorigenesis$595,751
R01 · FY2022 · CA
Analyzing the Hypersensitivity of MMR-deficient Colorectal Cancers to mTOR Inhibition and the Response of Cancer Stem Cells$396,750
R01 · FY2022 · CA · contact PI
Genetic and Dietary Interactions in MMR Deficient Colon Tumorigenesis$607,909
R01 · FY2021 · CA
Analyzing the Hypersensitivity of MMR-deficient Colorectal Cancers to mTOR Inhibition and the Response of Cancer Stem Cells$421,847
R01 · FY2021 · CA · contact PI
Gene Targeting & Transgenic Mouse$146,353
P30 · FY2021 · CA · contact PI
Genetic and Dietary Interactions in MMR Deficient Colon Tumorigenesis$607,909
R01 · FY2020 · CA
Genetic and Dietary Interactions in MMR Deficient Colon Tumorigenesis$167,500
R01 · FY2020 · CA
Gene Targeting & Transgenic Mouse$145,111
P30 · FY2020 · CA · contact PI
Genetic and Dietary Interactions in MMR Deficient Colon Tumorigenesis$595,590
R01 · FY2019 · CA
Gene Targeting & Transgenic Mouse$145,111
P30 · FY2019 · CA · contact PI
Genetic and Dietary Interactions in MMR Deficient Colon Tumorigenesis$457,547
R01 · FY2018 · CA
Genetic and Dietary Interactions in MMR Deficient Colon Tumorigenesis$177,759
R01 · FY2018 · CA
DNA Mismatch repair and cancer in murine models$380,585
R01 · FY2017 · CA · contact PI
DNA Mismatch repair and cancer in murine models$380,585
R01 · FY2016 · CA · contact PI
DNA Mismatch repair and cancer in murine models$356,052
R01 · FY2015 · CA · contact PI
DNA Mismatch repair and cancer in murine models$24,533
R01 · FY2015 · CA · contact PI
DNA Mismatch repair and cancer in murine models$369,167
R01 · FY2014 · CA · contact PI
DNA Mismatch repair and cancer in murine models$378,637
R01 · FY2013 · CA · contact PI
DNA mismatch repair and cancer in murine models$376,370
R01 · FY2012 · CA · contact PI
Identifying Conserved Genetic Networks for Eukaryotic MMR Genes$249,000
R21 · FY2012 · ES · contact PI
DNA mismatch repair and cancer in murine models$379,585
R01 · FY2011 · CA · contact PI
The Role of Late MMR Proteins in DNA Repair and Cancer$378,653
R01 · FY2011 · CA · contact PI
Identifying Conserved Genetic Networks for Eukaryotic MMR Genes$207,500
R21 · FY2011 · ES · contact PI
GENE TARGETING SHARED RESOURCE$166,031
P30 · FY2011 · CA · contact PI
DNA mismatch repair and cancer in murine models$394,734
R01 · FY2010 · CA · contact PI
The Role of Late MMR Proteins in DNA Repair and Cancer$390,363
R01 · FY2010 · CA · contact PI
GENE TARGETING SHARED RESOURCE$158,907
P30 · FY2010 · CA · contact PI
DNA mismatch repair and cancer in murine models$390,439
R01 · FY2009 · CA · contact PI
The Role of Late MMR Proteins in DNA Repair and Cancer$382,706
R01 · FY2009 · CA · contact PI
GENE TARGETING SHARED RESOURCE$174,088
P30 · FY2009 · CA · contact PI
DNA mismatch repair and cancer in murine models$380,983
R01 · FY2008 · CA · contact PI
The Role of Late MMR Proteins in DNA Repair and Cancer$371,559
R01 · FY2008 · CA · contact PI
GENE TARGETING SHARED RESOURCE$163,500
P30 · FY2008 · CA · contact PI
DNA MISMATCH REPAIR AND CANCER IN MURINE MODELS$372,114
R01 · FY2007 · CA · contact PI
The Role of Late MMR Proteins in DNA Repair and Cancer$367,883
R01 · FY2007 · CA · contact PI
GENE TARGETING SHARED RESOURCE$123,273
P30 · FY2007 · CA · contact PI
DNA MISMATCH REPAIR AND CANCER IN MURINE MODELS$64,315
R01 · FY2007 · CA · contact PI
DNA MISMATCH REPAIR AND CANCER IN MURINE MODELS$383,228
R01 · FY2006 · CA · contact PI
Exonuclease 1 in DNA Meiosis, Mismatch Repair and Canc$361,570
R01 · FY2006 · CA · contact PI
DNA MISMATCH REPAIR AND CANCER IN MURINE MODELS$62,417
R01 · FY2006 · CA · contact PI
DNA MISMATCH REPAIR AND CANCER IN MURINE MODELS$392,450
R01 · FY2005 · CA
Exonuclease 1 in DNA Meiosis, Mismatch Repair and Canc$370,309
R01 · FY2005 · CA
DNA MISMATCH REPAIR AND CANCER IN MURINE MODELS$47,000
R01 · FY2005 · CA
DNA MISMATCH REPAIR AND CANCER IN MURINE MODELS$392,450
R01 · FY2004 · CA
Exonuclease 1 in DNA Meiosis, Mismatch Repair and Canc$370,347
R01 · FY2004 · CA
DNA MISMATCH REPAIR AND CANCER IN MURINE MODELS$392,450
R01 · FY2003 · CA
Exonuclease 1 in DNA Meiosis, Mismatch Repair and Canc$370,382
R01 · FY2003 · CA
Exonuclease 1 in DNA Meiosis, Mismatch Repair and Canc$365,248
R01 · FY2002 · CA
DNA MISMATCH REPAIR AND CANCER IN MURINE MODELS$333,789
R01 · FY2002 · CA
DNA MISMATCH REPAIR AND CANCER IN MURINE MODELS$324,070
R01 · FY2001 · CA
DNA MISMATCH REPAIR AND CANCER IN MURINE MODELS$314,629
R01 · FY2000 · CA